NF1 and neurofibromatosis type 1: Indeed, as often happens when dealing with rare disorders, only 21 NF1 patients have been included in this study, obviously limiting our statistical power in possibly observing a small difference between the different groups (as proven by a posthoc power calculation showing that 43 NF-1 patients would have been needed to reach a power of 80%).